The observations that increasing OLA1 expression or reducing CHIP expression restore SOD2 function (124) suggest that its inactivation is possibly reversible and that OLA1 and CHIP are potential therapeutic targets for PPHN, to be explored in future studies. The gene discussed is STUB1; the disease is persistent fetal circulation syndrome.